Prenatal iron exposure and childhood type 1 diabetes.

Sci Rep 2018 06 13;8(1):9067. Epub 2018 Jun 13.

Department of non-communicable diseases, Norwegian Institute of Public Health, Oslo, Norway.

Iron overload due to environmental or genetic causes have been associated diabetes. We hypothesized that prenatal iron exposure is associated with higher risk of childhood type 1 diabetes. In the Norwegian Mother and Child cohort study (n = 94,209 pregnancies, n = 373 developed type 1 diabetes) the incidence of type 1 diabetes was higher in children exposed to maternal iron supplementation than unexposed (36.8/100,000/year compared to 28.6/100,000/year, adjusted hazard ratio 1.33, 95%CI: 1.06-1.67). Cord plasma biomarkers of high iron status were non-significantly associated with higher risk of type 1 diabetes (ferritin OR = 1.05 [95%CI: 0.99-1.13] per 50 mg/L increase; soluble transferrin receptor: OR = 0.91 [95%CI: 0.81-1.01] per 0.5 mg/L increase). Maternal but not fetal HFE genotypes causing high/intermediate iron stores were associated with offspring diabetes (odds ratio: 1.45, 95%CI: 1.04, 2.02). Maternal anaemia or non-iron dietary supplements did not significantly predict type 1 diabetes. Perinatal iron exposures were not associated with cord blood DNA genome-wide methylation, but fetal HFE genotype was associated with differential fetal methylation near HFE. Maternal cytokines in mid-pregnancy of the pro-inflammatory M1 pathway differed by maternal iron supplements and HFE genotype. Our results suggest that exposure to iron during pregnancy may be a risk factor for type 1 diabetes in the offspring.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-018-27391-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998022PMC
June 2018
20 Reads

Publication Analysis

Top Keywords

type diabetes
28
diabetes
9
childhood type
8
maternal iron
8
iron
8
hfe genotype
8
prenatal iron
8
higher risk
8
iron exposure
8
associated higher
8
fetal hfe
8
type
7
associated
6
maternal
5
odds ratio
4
hfe genotypes
4
ratio 145
4
145 95%ci
4
95%ci 104
4
hfe
4

References

(Supplied by CrossRef)

MA Atkinson et al.
Lancet 2014

M Rewers et al.
Lancet 2016

P Concannon et al.
N Engl J Med 2009

PC Calder et al.
Br J Nutr 2006

AC Palmer et al.
Adv Nutr 2011

S Rautava et al.
Nat Rev Gastroenterol Hepatol 2012

LC Stene et al.
Diabetologia 2013

KM Utzschneider et al.
Nat Rev Endocrinol 2010

KJ Allen et al.
N Engl J Med 2008

K Thorstensen et al.
Scand J Clin Lab Invest 2010

Similar Publications